8 Apr 2025
💊USITC Notice of Complaint on Certain Drug Products and Public Interest
Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
Summary
Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof, DN 3819; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure.
Agencies
- International Trade Commission
Business Impact
$$$ - High
The text outlines a legal complaint regarding drug products that could lead to exclusion orders affecting imports and sales. This has potential financial implications for companies involved, particularly BioMarin Pharmaceutical Inc. and the named respondents, as well as impacting competitive conditions and public health.